<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04731090</url>
  </required_header>
  <id_info>
    <org_study_id>N2113</org_study_id>
    <nct_id>NCT04731090</nct_id>
  </id_info>
  <brief_title>Standard Antibiotic Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy</brief_title>
  <official_title>Effect of Standard Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Egyptian Biomedical Research Network</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Egyptian Biomedical Research Network</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background and aim: Urinary tract infections (UTIs) are commonly seen after flexible&#xD;
      ureteroscopy. Prevention of UTIs remains controversial. The present randomized study aimed to&#xD;
      compare the rate of post-procedural UTI in patients subjected to the standard antibiotic&#xD;
      prophylaxis alone versus enhanced prophylactic measures.&#xD;
&#xD;
      Patients and methods: The study included 100 patients subjected to fURS for management of&#xD;
      ureteral and/or renal stones. Patients were equally and randomly allocated into one of the&#xD;
      two treatment groups using randomly computer-generated allocation tables and concealed&#xD;
      envelope technique. Treatment groups included standard antibiotic prophylaxis group and&#xD;
      enhanced prophylaxis group. Patients in the standard antibiotic prophylaxis group IV&#xD;
      fluoroquinolone 1 hour preoperatively and oral antibiotics were used for 24h postoperatively.&#xD;
      In the enhanced prophylaxis group, patients had urine culture 10 days before the procedure.&#xD;
      In addition to the antibiotic prophylaxis, hydrophilic-coated ureteral access sheaths were&#xD;
      systematically used.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">September 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 30, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Urinary tract infection</measure>
    <time_frame>30-day postoperative</time_frame>
    <description>Postoperative UTI was defined as the occurrence of a temperature higher than 38 Â°C associated with pyuria and/or bacteriuria without any other focal infectious sites.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>Standard antibiotic prophylaxis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV fluoroquinolone 1 hour preoperatively and oral antibiotics were used for 24h postoperatively.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>enhanced prophylaxis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients had urine culture 10 days before the procedure. In addition to the antibiotic prophylaxis, hydrophilic-coated ureteral access sheaths were systematically used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IV fluoroquinolone 1 hour preoperatively and oral antibiotics for 24h postoperatively.</intervention_name>
    <description>IV fluoroquinolone 1 hour preoperatively and oral antibiotics for 24h postoperatively.</description>
    <arm_group_label>Standard antibiotic prophylaxis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Urine culture, antibiotic prophylaxis and hydrophilic-coated ureteral access sheaths</intervention_name>
    <description>Patients had urine culture 10 days before the procedure. In addition to the antibiotic prophylaxis, hydrophilic-coated ureteral access sheaths were systematically used.</description>
    <arm_group_label>enhanced prophylaxis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients subjected to flexible ureteroscopy for management of ureteral and/or&#xD;
             renal stones.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Symptomatic urinary tract infection.&#xD;
&#xD;
          -  Use of rigid ureteroscopy and antegrade ureteroscopy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mohamed Elhelaly</last_name>
    <role>Principal Investigator</role>
    <affiliation>Al-Azhar Universiy</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Armed forced Hospital</name>
      <address>
        <city>Mecca</city>
        <country>Saudi Arabia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Saudi Arabia</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 25, 2021</study_first_submitted>
  <study_first_submitted_qc>January 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 29, 2021</study_first_posted>
  <last_update_submitted>January 28, 2021</last_update_submitted>
  <last_update_submitted_qc>January 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Fluoroquinolones</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

